JSON

Strain sc|0025679

Name

Acinetobacter baumannii

Strain numbers

ATCC 19606 = CCUG 19096 = CIP 70.34 = DSM 30007 = DSM 6974 = JCM 6841 = LMG 1041 = NCCB 85021 = NCTC 12156

StrainInfo: SI-ID 92085 T

Taxon
Acinetobacter baumannii
Sample
Urine
Cultures (26)
LMG 1041 = ATCC 19606 = CCUG 19096 = DSM 30007 = IAM 12088 = LMG 10545 = NCIMB 12457 = NCTC 12156 = DSM 6974 = NCIB 12457 = JCM 6841 = LMD 85.21 = KCTC 2508 = NCCB 85021 = NCCB 96002 = LMD 96.2 = NCCB 96128 = LMD 96.128 = BCRC 10591 = CCRC 10591 = NCAIM B.01930 = CIP 7034 = NCAIM B.02074 = CNCTC 6168 = VTT E-981116 = CIP 70.34
Other Designations (13)
Hugh 2208 = Dijkshoorn serial no. 35 = Schaub 81 = Bouvet and Grimont 4 = CNCTC B 5/78 = FIRDI 591 = RUH 3023 = Diikshoorn AC1099 = E.O. King = Bouvet & Grimont4 = LMG1041T QC 6/03 = Bouvet #4 = 2208
Sequences (75)
Associated Publications (213)
  • DOI: 10.1016/j.phymed.2011.11.010
    Duarte A, Ferreira S, Silva F, Domingues FC (2012). Synergistic activity of coriander oil and conventional antibiotics against Acinetobacter baumannii.
  • DOI: 10.1049/iet-nbt.2014.0052
    Khatami M, Pourseyedi S (2015). Phoenix dactylifera (date palm) pit aqueous extract mediated novel route for synthesis high stable silver nanoparticles with high antifungal and antibacterial activity.
  • DOI: 10.1016/0378-1097(94)90253-4
    Ikai H, Yamamoto S (1994). Cloning and expression in Escherichia coli of the gene encoding a novel L-2,4-diaminobutyrate decarboxylase of Acinetobacter baumannii.
  • DOI: 10.1016/s0934-8840(11)80403-2
    Traub WH, Bauer D (1993). Immunobiology of Acinetobacter baumannii and genospecies 3.
  • DOI: 10.1093/jac/45.suppl_3.71
    Higgins PG, Coleman K, Amyes SG (2000). Bactericidal and bacteriostatic activity of gemifloxacin against Acinetobacter spp. in vitro.
  • DOI: 10.1186/1471-2180-1-16
    Goel VK, Kapil A (2001). Monoclonal antibodies against the iron regulated outer membrane Proteins of Acinetobacter baumannii are bactericidal.
  • DOI: 10.1046/j.0014-2956.2001.02647.x
    Vinogradov EV, Duus JO, Brade H, Holst O (2002). The structure of the carbohydrate backbone of the lipopolysaccharide from Acinetobacter baumannii strain ATCC 19606.
  • DOI: 10.1099/mic.0.27141-0
    Mihara K, Tanabe T, Yamakawa Y, Funahashi T, Nakao H, Narimatsu S, Yamamoto S (2004). Identification and transcriptional organization of a gene cluster involved in biosynthesis and transport of acinetobactin, a siderophore produced by Acinetobacter baumannii ATCC 19606T.
  • DOI: 10.1099/mic.0.27371-0
    Dorsey CW, Tomaras AP, Connerly PL, Tolmasky ME, Crosa JH, Actis LA (2004). The siderophore-mediated iron acquisition systems of Acinetobacter baumannii ATCC 19606 and Vibrio anguillarum 775 are structurally and functionally related.
  • DOI: 10.1128/AAC.00103-06
    Li J, Rayner CR, Nation RL, Owen RJ, Spelman D, Tan KE, Liolios L (2006). Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.
  • DOI: 10.1093/jac/dkl512
    Owen RJ, Li J, Nation RL, Spelman D (2007). In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates.
  • DOI: 10.1111/j.1469-0691.2008.02010.x
    Wisplinghoff H, Hippler C, Bartual SG, Haefs C, Stefanik D, Higgins PG, Seifert H (2008). Molecular epidemiology of clinical Acinetobacter baumannii and Acinetobacter genomic species 13TU isolates using a multilocus sequencing typing scheme.
  • DOI: 10.1002/pmic.200800434
    Fernandez-Reyes M, Rodriguez-Falcon M, Chiva C, Pachon J, Andreu D, Rivas L (2009). The cost of resistance to colistin in Acinetobacter baumannii: a proteomic perspective.
  • DOI: 10.1097/CCM.0b013e31819c3e22
    Cirioni O, Silvestri C, Ghiselli R, Orlando F, Riva A, Gabrielli E, Mocchegiani F, Cianforlini N, Trombettoni MM, Saba V, Scalise G, Giacometti A (2009). Therapeutic efficacy of buforin II and rifampin in a rat model of Acinetobacter baumannii sepsis.
  • DOI: 10.1016/j.resmic.2009.01.002
    de Breij A, Gaddy J, van der Meer J, Koning R, Koster A, van den Broek P, Actis L, Nibbering P, Dijkshoorn L (2009). CsuA/BABCDE-dependent pili are not involved in the adherence of Acinetobacter baumannii ATCC19606(T) to human airway epithelial cells and their inflammatory response.
  • DOI: 10.1128/AAC.00856-09
    Higgins PG, Poirel L, Lehmann M, Nordmann P, Seifert H (2009). OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii.
  • DOI: 10.1021/pr9011188
    Vashist J, Tiwari V, Kapil A, Rajeswari MR (2010). Quantitative profiling and identification of outer membrane proteins of beta-lactam resistant strain of Acinetobacter baumannii.
  • DOI: 10.1093/jac/dkq226
    Dudhani RV, Turnidge JD, Nation RL, Li J (2010). fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models.
  • DOI: 10.1099/jmm.0.020339-0
    Cardoso K, Gandra RF, Wisniewski ES, Osaku CA, Kadowaki MK, Felipach-Neto V, Haus LFA, Simao RCG (2010). DnaK and GroEL are induced in response to antibiotic and heat shock in Acinetobacter baumannii.
  • DOI: 10.2174/092986710792231996
    Rosato A, Piarulli M, Corbo F, Muraglia M, Carone A, Vitali ME, Vitali C (2010). In vitro synergistic antibacterial action of certain combinations of gentamicin and essential oils.
  • DOI: 10.1016/j.jprot.2010.07.010
    Nwugo CC, Gaddy JA, Zimbler DL, Actis LA (2010). Deciphering the iron response in Acinetobacter baumannii: A proteomics approach.
  • DOI: 10.1128/AAC.00834-10
    Moffatt JH, Harper M, Harrison P, Hale JD, Vinogradov E, Seemann T, Henry R, Crane B, St Michael F, Cox AD, Adler B, Nation RL, Li J, Boyce JD (2010). Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production.
  • DOI: 10.1093/jac/dkq422
    Soon RL, Nation RL, Cockram S, Moffatt JH, Harper M, Adler B, Boyce JD, Larson I, Li J (2010). Different surface charge of colistin-susceptible and -resistant Acinetobacter baumannii cells measured with zeta potential as a function of growth phase and colistin treatment.
  • DOI: 10.1016/j.diagmicrobio.2010.09.008
    Islam AH, Singh KK, Ismail A (2011). Demonstration of an outer membrane protein that is antigenically specific for Acinetobacter baumannii.
  • DOI: 10.1016/j.micpath.2011.01.008
    Smani Y, Docobo-Perez F, McConnell MJ, Pachon J (2011). Acinetobacter baumannii-induced lung cell death: role of inflammation, oxidative stress and cytosolic calcium.
  • DOI: 10.1371/journal.pone.0017027
    Jin JS, Kwon SO, Moon DC, Gurung M, Lee JH, Kim SI, Lee JC (2011). Acinetobacter baumannii secretes cytotoxic outer membrane protein A via outer membrane vesicles.
  • Vashist J, Tiwari V, Das R, Kapil A, Rajeswari MR (2011). Analysis of penicillin-binding proteins (PBPs) in carbapenem resistant Acinetobacter baumannii.
  • DOI: 10.1007/s12275-011-0343-7
    McQueary CN, Actis LA (2011). Acinetobacter baumannii biofilms: variations among strains and correlations with other cell properties.
  • DOI: 10.1128/AAC.00079-11
    Beceiro A, Llobet E, Aranda J, Bengoechea JA, Doumith M, Hornsey M, Dhanji H, Chart H, Bou G, Livermore DM, Woodford N (2011). Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system.
  • Xiang J, Sun Z, Song F, Huan JN (2011). [Expressions of pgaABC gene clusters and changes in biofilm phenotype of Acinetobacter baumannii in burn patients].
  • DOI: 10.1016/j.vaccine.2011.06.001
    McConnell MJ, Rumbo C, Bou G, Pachon J (2011). Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii.
  • DOI: 10.1016/j.ijantimicag.2011.08.016
    Kuo HY, Chang KC, Kuo JW, Yueh HW, Liou ML (2011). Imipenem: a potent inducer of multidrug resistance in Acinetobacter baumannii.
  • DOI: 10.1128/AAC.05191-11
    Henry R, Vithanage N, Harrison P, Seemann T, Coutts S, Moffatt JH, Nation RL, Li J, Harper M, Adler B, Boyce JD (2011). Colistin-resistant, lipopolysaccharide-deficient Acinetobacter baumannii responds to lipopolysaccharide loss through increased expression of genes involved in the synthesis and transport of lipoproteins, phospholipids, and poly-beta-1,6-N-acetylglucosamine.
  • DOI: 10.1007/s12275-011-1063-8
    Tamang MD, Kim S, Kim SM, Kong HH, Kim J (2011). Interaction of Acinetobacter baumannii 19606 and 1656-2 with Acanthamoeba castellanii.
  • DOI: 10.1097/PDM.0b013e31821bbb1e
    Zhang L, Ding G, Wei L, Pan X, Mei L, Zhang Y, Lu Y (2011). Establishment of a novel target-based real-time quantitative PCR method for Acinetobacter baumannii detection.
  • DOI: 10.1093/jac/dkr519
    Fernando D, Kumar A (2011). Growth phase-dependent expression of RND efflux pump- and outer membrane porin-encoding genes in Acinetobacter baumannii ATCC 19606.
  • DOI: 10.1128/IAI.06279-11
    Gaddy JA, Arivett BA, McConnell MJ, Lopez-Rojas R, Pachon J, Actis LA (2012). Role of acinetobactin-mediated iron acquisition functions in the interaction of Acinetobacter baumannii strain ATCC 19606T with human lung epithelial cells, Galleria mellonella caterpillars, and mice.
  • DOI: 10.1128/AAC.05975-11
    de Breij A, Haisma EM, Rietveld M, El Ghalbzouri A, van den Broek PJ, Dijkshoorn L, Nibbering PH (2012). Three-dimensional human skin equivalent as a tool to study Acinetobacter baumannii colonization.
  • DOI: 10.1007/s12275-012-1589-4
    Moon DC, Choi CH, Lee JH, Choi CW, Kim HY, Park JS, Kim SI, Lee JC (2012). Acinetobacter baumannii outer membrane protein A modulates the biogenesis of outer membrane vesicles.
  • DOI: 10.1128/JB.00213-12
    Zimbler DL, Park TM, Arivett BA, Penwell WF, Greer SM, Woodruff TM, Tierney DL, Actis LA (2012). Stress response and virulence functions of the Acinetobacter baumannii NfuA Fe-S scaffold protein.
  • DOI: 10.1371/journal.pone.0036493
    Penwell WF, Arivett BA, Actis LA (2012). The Acinetobacter baumannii entA gene located outside the acinetobactin cluster is critical for siderophore production, iron acquisition and virulence.
  • Xiang J, Sun Z, Yang XG, Huan JN (2012). [Changes in expression of gene aba I in biofilm of Acinetobacter baumannii strains isolated from burn patients].
  • DOI: 10.1016/j.ijantimicag.2012.11.013
    Hornsey M, Phee L, Longshaw C, Wareham DW (2013). In vivo efficacy of telavancin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection.
  • DOI: 10.1016/j.resmic.2013.02.007
    Koning RI, de Breij A, Oostergetel GT, Nibbering PH, Koster AJ, Dijkshoorn L (2013). Cryo-electron tomography analysis of membrane vesicles from Acinetobacter baumannii ATCC19606 T.
  • DOI: 10.1007/s10096-013-1875-z
    Phee L, Hornsey M, Wareham DW (2013). In vitro activity of daptomycin in combination with low-dose colistin against a diverse collection of Gram-negative bacterial pathogens.
  • DOI: 10.1128/IAI.00540-13
    Zimbler DL, Arivett BA, Beckett AC, Menke SM, Actis LA (2013). Functional features of TonB energy transduction systems of Acinetobacter baumannii.
  • DOI: 10.1371/journal.pone.0071751
    Jun SH, Lee JH, Kim BR, Kim SI, Park TI, Lee JC, Lee YC (2013). Acinetobacter baumannii outer membrane vesicles elicit a potent innate immune response via membrane proteins.
  • DOI: 10.1128/AAC.00692-13
    Kwon DH, Hekmaty S, Seecoomar G (2013). Homeostasis of glutathione is associated with polyamine-mediated beta-lactam susceptibility in Acinetobacter baumannii ATCC 19606.
  • DOI: 10.1016/j.micres.2013.09.004
    Chusri S, Na-Phatthalung P, Siriyong T, Paosen S, Voravuthikunchai SP (2013). Holarrhena antidysenterica as a resistance modifying agent against Acinetobacter baumannii: Its effects on bacterial outer membrane permeability and efflux pumps.
  • DOI: 10.1128/AAC.01597-13
    Beceiro A, Moreno A, Fernandez N, Vallejo JA, Aranda J, Adler B, Harper M, Boyce JD, Bou G (2013). Biological cost of different mechanisms of colistin resistance and their impact on virulence in Acinetobacter baumannii.
  • DOI: 10.1155/2013/804940
    He XD, Wang Y, Wu Q, Wang HX, Chen ZD, Zheng RS, Wang ZS, Wang JB, Yang Y (2013). Xuebijing Protects Rats from Sepsis Challenged with Acinetobacter baumannii by Promoting Annexin A1 Expression and Inhibiting Proinflammatory Cytokines Secretion.
  • DOI: 10.1167/iovs.13-13401
    Talreja D, Kaye KS, Yu FS, Walia SK, Kumar A (2014). Pathogenicity of ocular isolates of Acinetobacter baumannii in a mouse model of bacterial endophthalmitis.
  • DOI: 10.1016/j.ijantimicag.2014.03.004
    Lin CH, Su SC, Ho KH, Hsu YW, Lee KR (2014). Bactericidal effect of sulbactam against Acinetobacter baumannii ATCC 19606 studied by 2D-DIGE and mass spectrometry.
  • DOI: 10.1111/1574-6968.12496
    Tilley D, Law R, Warren S, Samis JA, Kumar A (2014). CpaA a novel protease from Acinetobacter baumannii clinical isolates deregulates blood coagulation.
  • DOI: 10.1128/IAI.01958-14
    Ketter PM, Guentzel MN, Schaffer B, Herzig M, Wu X, Montgomery RK, Parida BK, Fedyk CG, Yu JJ, Jorgensen J, Chambers JP, Cap AP, Arulanandam BP (2014). Severe Acinetobacter baumannii sepsis is associated with elevation of pentraxin 3.
  • DOI: 10.1111/1574-6968.12530
    Bazyleu A, Kumar A (2014). Incubation temperature, osmolarity, and salicylate affect the expression of resistance-nodulation-division efflux pumps and outer membrane porins in Acinetobacter baumannii ATCC19606T.
  • DOI: 10.1016/S1995-7645(14)60074-2
    Chusri S, Siriyong T, Na-Phatthalung P, Voravuthikunchai SP (2014). Synergistic effects of ethnomedicinal plants of Apocynaceae family and antibiotics against clinical isolates of Acinetobacter baumannii.
  • DOI: 10.1371/journal.pone.0103456
    Zhang C, He X, Gu Y, Zhou H, Cao J, Gao Q (2014). Recombinant scorpine produced using SUMO fusion partner in Escherichia coli has the activities against clinically isolated bacteria and inhibits the Plasmodium falciparum parasitemia in vitro.
  • DOI: 10.1016/j.micpath.2014.07.007
    Darvish Alipour Astaneh S, Rasooli I, Mousavi Gargari SL (2014). The role of filamentous hemagglutinin adhesin in adherence and biofilm formation in Acinetobacter baumannii ATCC19606(T).
  • DOI: 10.1128/genomeA.00832-14
    Davenport KW, Daligault HE, Minogue TD, Bruce DC, Chain PS, Coyne SR, Jaissle JG, Koroleva GI, Ladner JT, Li PE, Palacios GF, Scholz MB, Teshima H, Johnson SL (2014). Draft Genome Assembly of Acinetobacter baumannii ATCC 19606.
  • DOI: 10.1089/mab.2013.0073
    Baig A, Cabral TM, Corbett CR (2014). Development and characterization of monoclonal antibodies for rapid detection of Acinetobacter baumannii.
  • DOI: 10.1038/ja.2014.150
    Sun C, Hao J, Dou M, Gong Y (2014). Mutant prevention concentrations of levofloxacin, pazufloxacin and ciprofloxacin for A. baumannii and mutations in gyrA and parC genes.
  • DOI: 10.1016/j.ijantimicag.2014.10.012
    Yang H, Chen G, Hu L, Liu Y, Cheng J, Li H, Ye Y, Li J (2014). In vivo activity of daptomycin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection.
  • DOI: 10.1371/journal.pone.0114410
    Garcia-Quintanilla M, Pulido MR, Pachon J, McConnell MJ (2014). Immunization with lipopolysaccharide-deficient whole cells provides protective immunity in an experimental mouse model of Acinetobacter baumannii infection.
  • DOI: 10.1128/IAI.02925-14
    Fiester SE, Nwugo CC, Penwell WF, Neary JM, Beckett AC, Arivett BA, Schmidt RE, Geiger SC, Connerly PL, Menke SM, Tomaras AP, Actis LA (2015). Role of the carboxy terminus of SecA in iron acquisition, protein translocation, and virulence of the bacterial pathogen Acinetobacter baumannii.
  • DOI: 10.1128/AAC.04379-14
    Yadav R, Landersdorfer CB, Nation RL, Boyce JD, Bulitta JB (2015). Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumannii.
  • DOI: 10.1159/000371815
    Badmasti F, Shahcheraghi F, Siadat SD, Bouzari S, Ajdary S, Amin M, Halabian R, Imani Fooladi AA (2015). Heterologous expression of 3-O-deacylase in Acinetobacter baumannii modulates the endotoxicity of lipopolysaccharide.
  • DOI: 10.1089/mdr.2014.0236
    Kim HA, Ryu SY, Seo I, Suh SI, Suh MH, Baek WK (2015). Biofilm Formation and Colistin Susceptibility of Acinetobacter baumannii Isolated from Korean Nosocomial Samples.
  • DOI: 10.1128/AEM.03975-14
    Oh MH, Lee JC, Kim J, Choi CH, Han K (2015). Simple Method for Markerless Gene Deletion in Multidrug-Resistant Acinetobacter baumannii.
  • DOI: 10.1186/s12866-015-0397-5
    Luo LM, Wu LJ, Xiao YL, Zhao D, Chen ZX, Kang M, Zhang Q, Xie Y (2015). Enhancing pili assembly and biofilm formation in Acinetobacter baumannii ATCC19606 using non-native acyl-homoserine lactones.
  • DOI: 10.1016/j.ijantimicag.2015.05.021
    Vallejo JA, Beceiro A, Rumbo-Feal S, Rodriguez-Palero MJ, Russo TA, Bou G (2015). Optimisation of the Caenorhabditis elegans model for studying the pathogenesis of opportunistic Acinetobacter baumannii.
  • DOI: 10.1016/j.molimm.2015.07.031
    Badmasti F, Ajdary S, Bouzari S, Fooladi AA, Shahcheraghi F, Siadat SD (2015). Immunological evaluation of OMV(PagL)+Bap(1-487aa) and AbOmpA(8-346aa)+Bap(1-487aa) as vaccine candidates against Acinetobacter baumannii sepsis infection.
  • DOI: 10.1371/journal.pone.0138360
    Stahl J, Bergmann H, Gottig S, Ebersberger I, Averhoff B (2015). Acinetobacter baumannii Virulence Is Mediated by the Concerted Action of Three Phospholipases D.
  • DOI: 10.1128/AAC.01472-15
    Arivett BA, Fiester SE, Ohneck EJ, Penwell WF, Kaufman CM, Relich RF, Actis LA (2015). Antimicrobial Activity of Gallium Protoporphyrin IX against Acinetobacter baumannii Strains Displaying Different Antibiotic Resistance Phenotypes.
  • DOI: 10.1093/jac/dkv378
    Komp Lindgren P, Higgins PG, Seifert H, Cars O (2015). Prevalence of hypermutators among clinical Acinetobacter baumannii isolates.
  • DOI: 10.1128/JB.00639-15
    Bojkovic J, Richie DL, Six DA, Rath CM, Sawyer WS, Hu Q, Dean CR (2015). Characterization of an Acinetobacter baumannii lptD Deletion Strain: Permeability Defects and Response to Inhibition of Lipopolysaccharide and Fatty Acid Biosynthesis.
  • DOI: 10.1016/j.jmii.2015.10.010
    Wei W, Yang H, Hu L, Ye Y, Li J (2015). Activity of levofloxacin in combination with colistin against Acinetobacter baumannii: In vitro and in a Galleria mellonella model.
  • DOI: 10.3906/sag-1407-45
    Sangroodi YH, Rasooli I, Nazarian S, Ebrahimizadeh W, Sefid F (2015). Immunogenicity of conserved cork and beta-barrel domains of baumannii acinetobactin utilization protein in an animal model.
  • DOI: 10.1007/s00203-016-1200-1
    Bravo Z, Orruno M, Parada C, Kaberdin VR, Barcina I, Arana I (2016). The long-term survival of Acinetobacter baumannii ATCC 19606(T) under nutrient-deprived conditions does not require the entry into the viable but non-culturable state.
  • DOI: 10.1089/mdr.2015.0270
    Tiwari M, Roy R, Tiwari V (2016). Screening of Herbal-Based Bioactive Extract Against Carbapenem-Resistant Strain of Acinetobacter baumannii.
  • DOI: 10.1038/srep22287
    Maifiah MH, Cheah SE, Johnson MD, Han ML, Boyce JD, Thamlikitkul V, Forrest A, Kaye KS, Hertzog P, Purcell AW, Song J, Velkov T, Creek DJ, Li J (2016). Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumannii.
  • DOI: 10.1128/AAC.03010-15
    Zander E, Seifert H, Higgins PG (2016). Effects of Saline, an Ambient Acidic Environment, and Sodium Salicylate on OXA-Mediated Carbapenem Resistance in Acinetobacter baumannii.
  • DOI: 10.1016/j.marpolbul.2016.03.060
    Nkem BM, Halimoon N, Yusoff FM, Johari WLW, Zakaria MP, Medipally SR, Kannan N (2016). Isolation, identification and diesel-oil biodegradation capacities of indigenous hydrocarbon-degrading strains of Cellulosimicrobium cellulans and Acinetobacter baumannii from tarball at Terengganu beach, Malaysia.
  • DOI: 10.3389/fmicb.2016.00483
    Qi L, Li H, Zhang C, Liang B, Li J, Wang L, Du X, Liu X, Qiu S, Song H (2016). Relationship between Antibiotic Resistance, Biofilm Formation, and Biofilm-Specific Resistance in Acinetobacter baumannii.
  • DOI: 10.1016/j.ijantimicag.2016.03.010
    Lopez-Rojas R, Garcia-Quintanilla M, Labrador-Herrera G, Pachon J, McConnell MJ (2016). Impaired growth under iron-limiting conditions associated with the acquisition of colistin resistance in Acinetobacter baumannii.
  • DOI: 10.1038/srep26233
    Cheah SE, Johnson MD, Zhu Y, Tsuji BT, Forrest A, Bulitta JB, Boyce JD, Nation RL, Li J (2016). Polymyxin Resistance in Acinetobacter baumannii: Genetic Mutations and Transcriptomic Changes in Response to Clinically Relevant Dosage Regimens.
  • DOI: 10.1016/j.jbiotec.2016.05.024
    Rasoulinejad S, Gargari SLM (2016). Aptamer-nanobody based ELASA for specific detection of Acinetobacter baumannii isolates.
  • DOI: 10.1016/j.pdpdt.2016.07.007
    Pourhajibagher M, Boluki E, Chiniforush N, Pourakbari B, Farshadzadeh Z, Ghorbanzadeh R, Aziemzadeh M, Bahador A (2016). Modulation of virulence in Acinetobacter baumannii cells surviving photodynamic treatment with toluidine blue.
  • DOI: 10.1016/j.ijantimicag.2016.06.006
    Rao GG, Ly NS, Diep J, Forrest A, Bulitta JB, Holden PN, Nation RL, Li J, Tsuji BT (2016). Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii.
  • DOI: 10.3390/md14080143
    Tseng SP, Hung WC, Huang CY, Lin YS, Chan MY, Lu PL, Lin L, Sheu JH (2016). 5-Episinuleptolide Decreases the Expression of the Extracellular Matrix in Early Biofilm Formation of Multi-Drug Resistant Acinetobacter baumannii.
  • DOI: 10.1093/jac/dkw293
    Rao GG, Ly NS, Bulitta JB, Soon RL, San Roman MD, Holden PN, Landersdorfer CB, Nation RL, Li J, Forrest A, Tsuji BT (2016). Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii: pharmacodynamics of new dosing strategies.
  • DOI: 10.1371/journal.pone.0160918
    Richie DL, Takeoka KT, Bojkovic J, Metzger LE 4th, Rath CM, Sawyer WS, Wei JR, Dean CR (2016). Toxic Accumulation of LPS Pathway Intermediates Underlies the Requirement of LpxH for Growth of Acinetobacter baumannii ATCC 19606.
  • DOI: 10.1093/jac/dkw355
    Lenhard JR, Bulitta JB, Connell TD, King-Lyons N, Landersdorfer CB, Cheah SE, Thamlikitkul V, Shin BS, Rao G, Holden PN, Walsh TJ, Forrest A, Nation RL, Li J, Tsuji BT (2016). High-intensity meropenem combinations with polymyxin B: new strategies to overcome carbapenem resistance in Acinetobacter baumannii.
  • DOI: 10.3904/kjim.2015.287
    Ryu SY, Baek WK, Kim HA (2016). Association of biofilm production with colonization among clinical isolates of Acinetobacter baumannii.
  • DOI: 10.1073/pnas.1611594113
    Boll JM, Crofts AA, Peters K, Cattoir V, Vollmer W, Davies BW, Trent MS (2016). A penicillin-binding protein inhibits selection of colistin-resistant, lipooligosaccharide-deficient Acinetobacter baumannii.
  • DOI: 10.1371/journal.pone.0167068
    Fiester SE, Arivett BA, Schmidt RE, Beckett AC, Ticak T, Carrier MV, Ghosh R, Ohneck EJ, Metz ML, Sellin Jeffries MK, Actis LA (2016). Iron-Regulated Phospholipase C Activity Contributes to the Cytolytic Activity and Virulence of Acinetobacter baumannii.
  • DOI: 10.1021/acsinfecdis.7b00183
    Ackerman DL, Craft KM, Doster RS, Weitkamp JH, Aronoff DM, Gaddy JA, Townsend SD (2017). Antimicrobial and Antibiofilm Activity of Human Milk Oligosaccharides against Streptococcus agalactiae, Staphylococcus aureus, and Acinetobacter baumannii.
  • DOI: 10.1039/c7md00354d
    Wang R, Hou S, Dong X, Chen D, Shao L, Qian L, Li Z, Xu X (2017). Synergism of fused bicyclic 2-aminothiazolyl compounds with polymyxin B against Klebsiella pneumoniae.
  • DOI: 10.1128/AEM.01334-19
    Lucidi M, Visaggio D, Prencipe E, Imperi F, Rampioni G, Cincotti G, Leoni L, Visca P (2019). New Shuttle Vectors for Real-Time Gene Expression Analysis in Multidrug-Resistant Acinetobacter Species: In Vitro and In Vivo Responses to Environmental Stressors.
  • DOI: 10.1038/s41429-020-00401-2
    Hui Z, Liu S, Cui R, Zhou B, Hu C, Zhang M, Deng Q, Cheng S, Luo Y, Chen H, Wu J, Lu Y, Liu X, Dai L, Huang W (2021). A small molecule interacts with pMAC-derived hydroperoxide reductase and enhances the activity of aminoglycosides.
  • DOI: 10.33073/pjm-2021-044
    Tansho-Nagakawa S, Sato Y, Ubagai T, Kikuchi-Ueda T, Kamoshida GO, Nishida S, Ono Y (2021). Histopathological Analysis of Acinetobacter baumannii Lung Infection in a Mouse Model.
  • DOI: 10.3390/pharmaceutics14040786
    Hussein M, Allobawi R, Levou I, Blaskovich MAT, Rao GG, Li J, Velkov T (2022). Mechanisms Underlying Synergistic Killing of Polymyxin B in Combination with Cannabidiol against Acinetobacter baumannii: A Metabolomic Study.
  • DOI: 10.3390/antibiotics11070978
    Glover JS, Ticer TD, Engevik MA (2022). Profiling Antibiotic Resistance in Acinetobacter calcoaceticus.
  • DOI: 10.3389/fcimb.2023.1210195
    Amer MA, Wasfi R, Hamed SM (2023). Biosurfactant from Nile Papyrus endophyte with potential antibiofilm activity against global clones of Acinetobacter baumannii.
  • DOI: 10.1021/acs.molpharmaceut.3c00734
    Rajchakit U, Lamba S, Wang K, Lyons N, Lu J, Swift S, Pletzer D, Sarojini V (2024). Size-Controlled Synthesis of Gold Nanoparticles Tethering Antimicrobial Peptides with Potent Broad-Spectrum Antimicrobial and Antibiofilm Activities.
  • DOI: 10.1099/jmm.0.000394
    Sato Y, Unno Y, Kawakami S, Ubagai T, Ono Y (2017). Virulence characteristics of Acinetobacter baumannii clinical isolates vary with the expression levels of omps.
  • DOI: 10.1016/j.ijantimicag.2016.11.031
    Wei WJ, Yang HF (2017). Synergy against extensively drug-resistant Acinetobacter baumannii in vitro by two old antibiotics: colistin and chloramphenicol.
  • DOI: 10.2741/e801
    Darwish Alipour Astaneh S, Rasooli I, Mousavi Gargari SL (2017). Filamentous hemagglutinin adhesin FhaB limits A.baumannii biofilm formation.
  • Afshar FF, Saffarian P, Hosseini HM, Sattarian F, Amin M, Fooladi AA (2016). Antimicrobial effects of Ferula gummosa Boiss gum against extended-spectrum beta-lactamase producing Acinetobacter clinical isolates.
  • DOI: 10.1093/jac/dkx131
    Chatterjee S, Mondal A, Mitra S, Basu S (2017). Acinetobacter baumannii transfers the blaNDM-1 gene via outer membrane vesicles.
  • DOI: 10.1038/s41598-017-03214-w
    Lopalco P, Stahl J, Annese C, Averhoff B, Corcelli A (2017). Identification of unique cardiolipin and monolysocardiolipin species in Acinetobacter baumannii.
  • DOI: 10.1038/s41598-017-03416-2
    Presta L, Bosi E, Mansouri L, Dijkshoorn L, Fani R, Fondi M (2017). Constraint-based modeling identifies new putative targets to fight colistin-resistant A. baumannii infections.
  • DOI: 10.1007/s00284-017-1283-1
    Hamouda A (2017). Identification of Acinetobacter baumannii of Human and Animal Origins by a Gene-Specific PCR.
  • DOI: 10.1128/AAC.00778-17
    Moon KH, Weber BS, Feldman MF (2017). Subinhibitory Concentrations of Trimethoprim and Sulfamethoxazole Prevent Biofilm Formation by Acinetobacter baumannii through Inhibition of Csu Pilus Expression.
  • DOI: 10.1021/acs.jnatprod.7b00063
    Hendra R, Keller PA (2017). Phytochemical Studies on Two Australian Anigozanthos Plant Species.
  • DOI: 10.1016/j.ijmm.2017.07.009
    Alharbe R, Almansour A, Kwon DH (2017). Antibacterial activity of exogenous glutathione and its synergism on antibiotics sensitize carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii.
  • DOI: 10.1128/mSphere.00199-17
    Wei JR, Richie DL, Mostafavi M, Metzger LE 4th, Rath CM, Sawyer WS, Takeoka KT, Dean CR (2017). LpxK Is Essential for Growth of Acinetobacter baumannii ATCC 19606: Relationship to Toxic Accumulation of Lipid A Pathway Intermediates.
  • DOI: 10.1128/IAI.00591-17
    Wang-Lin SX, Olson R, Beanan JM, MacDonald U, Balthasar JP, Russo TA (2017). The Capsular Polysaccharide of Acinetobacter baumannii Is an Obstacle for Therapeutic Passive Immunization Strategies.
  • DOI: 10.1016/j.micpath.2017.10.001
    Deihim B, Hassanzadeh M, Shafiei-Jandaghi NZ, Amanlou M, Douraghi M (2017). Characterization of the DNA mismatch repair proteins MutS and MutL in a hypermutator Acinetobacter baumannii.
  • DOI: 10.1371/journal.pone.0190599
    Ohneck EJ, Arivett BA, Fiester SE, Wood CR, Metz ML, Simeone GM, Actis LA (2018). Mucin acts as a nutrient source and a signal for the differential expression of genes coding for cellular processes and virulence factors in Acinetobacter baumannii.
  • DOI: 10.1371/journal.pone.0192288
    Wang J, Zhou Z, He F, Ruan Z, Jiang Y, Hua X, Yu Y (2018). The role of the type VI secretion system vgrG gene in the virulence and antimicrobial resistance of Acinetobacter baumannii ATCC 19606.
  • DOI: 10.1371/journal.pone.0193851
    Richie DL, Wang L, Chan H, De Pascale G, Six DA, Wei JR, Dean CR (2018). A pathway-directed positive growth restoration assay to facilitate the discovery of lipid A and fatty acid biosynthesis inhibitors in Acinetobacter baumannii.
  • DOI: 10.1371/journal.pone.0194556
    Sato Y, Unno Y, Ubagai T, Ono Y (2018). Sub-minimum inhibitory concentrations of colistin and polymyxin B promote Acinetobacter baumannii biofilm formation.
  • DOI: 10.1002/mbo3.614
    Zeidler S, Hubloher J, Konig P, Ngu ND, Scholz A, Averhoff B, Muller V (2018). Salt induction and activation of MtlD, the key enzyme in the synthesis of the compatible solute mannitol in Acinetobacter baumannii.
  • DOI: 10.1080/21505594.2018.1460187
    Carretero-Ledesma M, Garcia-Quintanilla M, Martin-Pena R, Pulido MR, Pachon J, McConnell MJ (2018). Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii.
  • DOI: 10.1089/mdr.2017.0341
    Alkasir R, Ma Y, Liu F, Li J, Lv N, Xue Y, Hu Y, Zhu B (2018). Characterization and Transcriptome Analysis of Acinetobacter baumannii Persister Cells.
  • DOI: 10.1007/s12602-018-9444-5
    Jaskiewicz M, Neubauer D, Kazor K, Bartoszewska S, Kamysz W (2019). Antimicrobial Activity of Selected Antimicrobial Peptides Against Planktonic Culture and Biofilm of Acinetobacter baumannii.
  • DOI: 10.1016/j.micres.2018.08.004
    Lin HR, Shu HY, Lin GH (2018). Biological roles of indole-3-acetic acid in Acinetobacter baumannii.
  • DOI: 10.1002/mbo3.740
    Zeidler S, Muller V (2018). The role of compatible solutes in desiccation resistance of Acinetobacter baumannii.
  • DOI: 10.1002/mbo3.752
    Breisch J, Waclawska I, Averhoff B (2018). Identification and characterization of a carnitine transporter in Acinetobacter baumannii.
  • DOI: 10.1128/AAC.01409-18
    Fiester SE, Arivett BA, Beckett AC, Wagner BR, Ohneck EJ, Schmidt RE, Grier JT, Actis LA (2018). Miltefosine Reduces the Cytolytic Activity and Virulence of Acinetobacter baumannii.
  • DOI: 10.1128/mSystems.00157-18
    Zhu Y, Zhao J, Maifiah MHM, Velkov T, Schreiber F, Li J (2019). Metabolic Responses to Polymyxin Treatment in Acinetobacter baumannii ATCC 19606: Integrating Transcriptomics and Metabolomics with Genome-Scale Metabolic Modeling.
  • DOI: 10.1093/jac/dkz024
    Foong WE, Tam HK, Crames JJ, Averhoff B, Pos KM (2019). The chloramphenicol/H+ antiporter CraA of Acinetobacter baumannii AYE reveals a broad substrate specificity.
  • DOI: 10.1016/j.jhin.2019.04.009
    Bravo Z, Orruno M, Navascues T, Ogayar E, Ramos-Vivas J, Kaberdin VR, Arana I (2019). Analysis of Acinetobacter baumannii survival in liquid media and on solid matrices as well as effect of disinfectants.
  • DOI: 10.3389/fcimb.2019.00203
    Mujawar S, Mishra R, Pawar S, Gatherer D, Lahiri C (2019). Delineating the Plausible Molecular Vaccine Candidates and Drug Targets of Multidrug-Resistant Acinetobacter baumannii.
  • DOI: 10.1089/wound.2018.0854
    Salisbury AM, Mullin M, Chen R, Percival SL (2019). Efficacy of Poloxamer-Based Wound Dressings on Acinetobacter baumanni Biofilms.
  • DOI: 10.1371/journal.pone.0219693
    Majumder A, Biswal MR, Prakash MK (2019). Computational screening of antimicrobial peptides for Acinetobacter baumannii.
  • DOI: 10.1038/s41598-019-53846-3
    Sato Y, Unno Y, Miyazaki C, Ubagai T, Ono Y (2019). Multidrug-resistant Acinetobacter baumannii resists reactive oxygen species and survives in macrophages.
  • DOI: 10.2147/IDR.S203919
    Eze EC, El Zowalaty ME (2019). Combined Effects Of Low Incubation Temperature, Minimal Growth Medium, And Low Hydrodynamics Optimize Acinetobacter baumannii Biofilm Formation.
  • DOI: 10.1016/j.ijantimicag.2019.105862
    Gerson S, Lucassen K, Wille J, Nodari CS, Stefanik D, Nowak J, Wille T, Betts JW, Roca I, Vila J, Cisneros JM, Seifert H, Higgins PG (2019). Diversity of amino acid substitutions in PmrCAB associated with colistin resistance in clinical isolates of Acinetobacter baumannii.
  • DOI: 10.1016/j.vaccine.2019.11.043
    Pulido MR, Garcia-Quintanilla M, Pachon J, McConnell MJ (2019). A lipopolysaccharide-free outer membrane vesicle vaccine protects against Acinetobacter baumannii infection.
  • DOI: 10.1080/21505594.2018.1558693
    Weidensdorfer M, Ishikawa M, Hori K, Linke D, Djahanschiri B, Iruegas R, Ebersberger I, Riedel-Christ S, Enders G, Leukert L, Kraiczy P, Rothweiler F, Cinatl J, Berger J, Hipp K, Kempf VAJ, Gottig S (2019). The Acinetobacter trimeric autotransporter adhesin Ata controls key virulence traits of Acinetobacter baumannii.
  • DOI: 10.1186/s12866-020-1722-1
    Kesavan D, Vasudevan A, Wu L, Chen J, Su Z, Wang S, Xu H (2020). Integrative analysis of outer membrane vesicles proteomics and whole-cell transcriptome analysis of eravacycline induced Acinetobacter baumannii strains.
  • DOI: 10.1093/jac/dkaa015
    Foong WE, Wilhelm J, Tam HK, Pos KM (2020). Tigecycline efflux in Acinetobacter baumannii is mediated by TetA in synergy with RND-type efflux transporters.
  • DOI: 10.1111/1462-2920.14951
    Zeidler S, Muller V (2020). Unusual deprivation of compatible solutes in Acinetobacter baumannii.
  • DOI: 10.1016/j.ijmm.2020.151412
    Zhu Y, Lu J, Zhao J, Zhang X, Yu HH, Velkov T, Li J (2020). Complete genome sequence and genome-scale metabolic modelling of Acinetobacter baumannii type strain ATCC 19606.
  • DOI: 10.1038/s41429-020-0289-2
    Chen L, Lin J, Lu H, Zhang X, Wang C, Liu H, Zhang X, Li J, Cao J, Zhou T (2020). Deciphering colistin heteroresistance in Acinetobacter baumannii clinical isolates from Wenzhou, China.
  • DOI: 10.1128/mSphere.00895-19
    Sun B, Liu H, Jiang Y, Shao L, Yang S, Chen D (2020). New Mutations Involved in Colistin Resistance in Acinetobacter baumannii.
  • DOI: 10.1016/j.scitotenv.2020.138232
    Narciso AC, Martins WMBS, Almeida LGP, Cayo R, Santos SV, Ramos PL, Lincopan N, Vasconcelos ATR, Gales AC (2020). Healthcare-associated carbapenem-resistant OXA-72-producing Acinetobacter baumannii of the clonal complex CC79 colonizing migratory and captive aquatic birds in a Brazilian Zoo.
  • DOI: 10.1556/030.2020.01138
    Abbasi E, Goudarzi H, Hashemi A, Chirani AS, Ardebili A, Goudarzi M, Sharahi JY, Davoudabadi S, Talebi G, Bostanghadiri N (2020). Decreased carO gene expression and OXA-type carbapenemases among extensively drug-resistant Acinetobacter baumannii strains isolated from burn patients in Tehran, Iran.
  • DOI: 10.1128/MRA.00289-20
    Tsubouchi T, Suzuki M, Niki M, Oinuma KI, Niki M, Kakeya H, Kaneko Y (2020). Complete Genome Sequence of Acinetobacter baumannii ATCC 19606(T), a Model Strain of Pathogenic Bacteria Causing Nosocomial Infection.
  • DOI: 10.1111/apm.13061
    Mahmoudi Z, Rasooli I, Jahangiri A, Darvish Alipour Astaneh S (2020). Prevention of nosocomial Acinetobacter baumannii infections with a conserved immunogenic fimbrial protein.
  • DOI: 10.1039/d0mo00015a
    Li M, Aye SM, Ahmed MU, Han ML, Li C, Song J, Boyce JD, Powell DR, Azad MAK, Velkov T, Zhu Y, Li J (2020). Pan-transcriptomic analysis identified common differentially expressed genes of Acinetobacter baumannii in response to polymyxin treatments.
  • DOI: 10.1111/1462-2920.15148
    Hubloher JJ, Zeidler S, Lamosa P, Santos H, Averhoff B, Muller V (2020). Trehalose-6-phosphate-mediated phenotypic change in Acinetobacter baumannii.
  • DOI: 10.1186/s12866-020-01957-7
    Li J, Yu T, Luo Y, Peng JY, Li YJ, Tao XY, Hu YM, Wang HC, Zou MX (2020). Characterization of carbapenem-resistant hypervirulent Acinetobacter baumannii strains isolated from hospitalized patients in the mid-south region of China.
  • DOI: 10.1111/1462-2920.15231
    Pfefferle K, Lopalco P, Breisch J, Siemund A, Corcelli A, Averhoff B (2020). In vivo synthesis of monolysocardiolipin and cardiolipin by Acinetobacter baumannii phospholipase D and effect on cationic antimicrobial peptide resistance.
  • DOI: 10.3390/microorganisms8121851
    Hamidian M, Blasco L, Tillman LN, To J, Tomas M, Myers GSA (2020). Analysis of Complete Genome Sequence of Acinetobacter baumannii Strain ATCC 19606 Reveals Novel Mobile Genetic Elements and Novel Prophage.
  • DOI: 10.3389/fimmu.2020.601614
    Sato Y, Tansho-Nagakawa S, Ubagai T, Ono Y (2020). Analysis of Immune Responses in Acinetobacter baumannii-Infected Klotho Knockout Mice: A Mouse Model of Acinetobacter baumannii Infection in Aged Hosts.
  • DOI: 10.1089/mdr.2019.0474
    Chen DJ, Cui AL, Chen JR, Yang P, Jin J, Shao L, Li ZR (2021). The Low-Alkalinity Polymyxin Derivative, AL-6, Shows High Activity Against Multidrug-Resistant Acinetobacter baumannii Clinical Isolates In Vitro and A. baumannii ATCC 19606 In Vivo: Preliminary Analysis of the Antibacterial Mechanism.
  • DOI: 10.1007/s10482-021-01517-7
    Pulami D, Schauss T, Eisenberg T, Blom J, Schwengers O, Bender JK, Wilharm G, Kampfer P, Glaeser SP (2021). Acinetobacter stercoris sp. nov. isolated from output source of a mesophilic german biogas plant with anaerobic operating conditions.
  • Rasidin RSM, Suhaili Z, Mohamed AFS, Hod R, Neela V, Amin-Nordin S (2020). Time-kill and post-antibiotic effect of colistin at different static concentrations in in vitro Acinetobacter baumannii.
  • DOI: 10.1371/journal.pone.0247513
    Bogue AL, Panmanee W, McDaniel CT, Mortensen JE, Kamau E, Actis LA, Johannigman JA, Schurr MJ, Satish L, Kotagiri N, Hassett DJ (2021). AB569, a non-toxic combination of acidified nitrite and EDTA, is effective at killing the notorious Iraq/Afghanistan combat wound pathogens, multi-drug resistant Acinetobacter baumannii and Acinetobacter spp.
  • DOI: 10.1016/j.bbamem.2021.183600
    Zeng P, Yi L, Xu J, Gao W, Xu C, Chen S, Chan KF, Wong KY (2021). Investigation of antibiofilm activity, antibacterial activity, and mechanistic studies of an amphiphilic peptide against Acinetobacter baumannii.
  • DOI: 10.3390/pathogens10030290
    Kikuchi-Ueda T, Ubagai T, Kamoshida G, Nakano R, Nakano A, Ono Y (2021). Acinetobacter baumannii LOS Regulate the Expression of Inflammatory Cytokine Genes and Proteins in Human Mast Cells.
  • DOI: 10.3390/microorganisms9030629
    Chen SJ, Shu HY, Lin GH (2021). Regulation of tert-Butyl Hydroperoxide Resistance by Chromosomal OhrR in A. baumannii ATCC 19606.
  • DOI: 10.3389/fcimb.2021.635673
    Grier JT, Arivett BA, Ramirez MS, Chosed RJ, Bigner JA, Ohneck EJ, Metz ML, Wood CR, Arce S, Tartaro A, Relich RF, Actis LA, Fiester SE (2021). Two Acinetobacter baumannii Isolates Obtained From a Fatal Necrotizing Fasciitis Infection Display Distinct Genomic and Phenotypic Characteristics in Comparison to Type Strains.
  • DOI: 10.1128/AAC.00570-21
    Lucassen K, Gerson S, Xanthopoulou K, Wille J, Wille T, Seifert H, Higgins PG (2021). Comparison of the Acinetobacter baumannii Reference Strains ATCC 17978 and ATCC 19606 in Antimicrobial Resistance Mediated by the AdeABC Efflux Pump.
  • DOI: 10.1016/j.ijmm.2021.151516
    Konig P, Averhoff B, Muller V (2021). K(+) and its role in virulence of Acinetobacter baumannii.
  • DOI: 10.1515/jcim-2021-0051
    Dos Santos Liberato SF, da Cruz Vegian MR, Abu Hasna A, de Alvarenga JA, Dos Santos JG, Tini IRP, Amendola I, Junqueira JC, de Oliveira LD (2021). Antibiofilm action of Persea americana glycolic extract over Acinetobacter baumannii and absence of toxicity in Galleria mellonella.
  • DOI: 10.1371/journal.ppat.1009802
    Sycz G, Di Venanzio G, Distel JS, Sartorio MG, Le NH, Scott NE, Beatty WL, Feldman MF (2021). Modern Acinetobacter baumannii clinical isolates replicate inside spacious vacuoles and egress from macrophages.
  • DOI: 10.1007/s10482-021-01640-5
    Wang S, Mu DS, Li GY, Du ZJ (2021). Description of Lujinxingia vulgaris sp. nov., isolated from coastal sediment via prey-traps.
  • DOI: 10.3390/ijms22189921
    Lin GH, Hsieh MC, Shu HY (2021). Role of Iron-Containing Alcohol Dehydrogenases in Acinetobacter baumannii ATCC 19606 Stress Resistance and Virulence.
  • DOI: 10.3389/fcimb.2021.734578
    Lu Y, Hu X, Nie T, Yang X, Li C, You X (2021). Strategies for Rapid Identification of Acinetobacter baumannii Membrane Proteins and Polymyxin B's Effects.
  • DOI: 10.3390/antibiotics10101259
    Olmeda-Lopez H, Corral-Lugo A, McConnell MJ (2021). Effect of Subinhibitory Concentrations of Antibiotics and Disinfectants on ISAba-Mediated Inactivation of Lipooligosaccharide Biosynthesis Genes in Acinetobacter baumannii.
  • DOI: 10.1016/j.micres.2021.126911
    Li H, Du X, Chen C, Qi J, Wang Y (2021). Integrating transcriptomics and metabolomics analysis on kojic acid combating Acinetobacter baumannii biofilm and its potential roles.
  • DOI: 10.1016/j.micpath.2021.105291
    Naghipour Erami A, Rasooli I, Jahangiri A, Darvish Alipour Astaneh S (2021). Anti-Omp34 antibodies protect against Acinetobacter baumannii in a murine sepsis model.
  • DOI: 10.1186/s12866-022-02439-8
    Farshadzadeh Z, Pourhajibagher M, Taheri B, Ekrami A, Modarressi MH, Azimzadeh M, Bahador A (2022). Antimicrobial and anti-biofilm potencies of dermcidin-derived peptide DCD-1L against Acinetobacter baumannii: an in vivo wound healing model.
  • DOI: 10.1099/mgen.0.000749
    Artuso I, Lucidi M, Visaggio D, Capecchi G, Lugli GA, Ventura M, Visca P (2022). Genome diversity of domesticated Acinetobacter baumannii ATCC 19606(T) strains.
  • DOI: 10.3389/fmed.2022.797104
    Guo T, Sun X, Li M, Wang Y, Jiao H, Li G (2022). The Involvement of the csy1 Gene in the Antimicrobial Resistance of Acinetobacter baumannii.
  • DOI: 10.3389/fmicb.2021.790263
    Migliaccio A, Esposito EP, Bagattini M, Berisio R, Triassi M, De Gregorio E, Zarrilli R (2022). Inhibition of AdeB, AceI, and AmvA Efflux Pumps Restores Chlorhexidine and Benzalkonium Susceptibility in Acinetobacter baumannii ATCC 19606.
  • DOI: 10.1186/s43141-022-00325-4
    Alipouri S, Rasooli I, Ghaini MH, Jahangiri A, Darvish Alipour Astaneh S, Ramezanalizadeh F (2022). Immunity induced by valine-glycine repeat protein G imparts histoprotection of vital body organs against Acinetobacter baumannii.
  • DOI: 10.1111/jam.15609
    Elshaer SL, Shaldam MA, Shaaban MI (2022). Ketoprofen, piroxicam and indomethacin-suppressed quorum sensing and virulence factors in Acinetobacter baumannii.
  • DOI: 10.3389/fmicb.2022.867770
    Yang R, Lai B, Liao K, Liu B, Huang L, Li S, Gu J, Lin Z, Chen Y, Wang S, Qiu Y, Deng J, Chen S, Zhuo C, Zhou Y (2022). Overexpression of BIT33_RS14560 Enhances the Biofilm Formation and Virulence of Acinetobacter baumannii.
  • DOI: 10.1186/s12866-022-02612-z
    Xiong L, Yi F, Yu Q, Huang X, Ao K, Wang Y, Xie Y (2022). Transcriptomic analysis reveals the regulatory role of quorum sensing in the Acinetobacter baumannii ATCC 19606 via RNA-seq.
  • DOI: 10.3389/fmicb.2022.967949
    Chai WC, Whittall JJ, Polyak SW, Foo K, Li X, Dutschke CJ, Ogunniyi AD, Ma S, Sykes MJ, Semple SJ, Venter H (2022). Cinnamaldehyde derivatives act as antimicrobial agents against Acinetobacter baumannii through the inhibition of cell division.
  • DOI: 10.1089/phage.2020.0043
    Pehde BM, Niewohner D, Keomanivong FE, Carruthers MD (2021). Genome Sequence and Characterization of Acinetobacter Phage DMU1.
  • DOI: 10.1128/spectrum.02347-22
    Stracquadanio S, Bonomo C, Marino A, Bongiorno D, Privitera GF, Bivona DA, Mirabile A, Bonacci PG, Stefani S (2022). Acinetobacter baumannii and Cefiderocol, between Cidality and Adaptability.
  • DOI: 10.1016/j.micres.2022.127222
    Zou D, Chang J, Lu S, Xu J, Hu P, Zhang K, Sun X, Guo W, Li Y, Liu Z, Ren H (2022). Analysis of virulence proteins in pathogenic Acinetobacter baumannii to provide early warning of zoonotic risk.
  • DOI: 10.1002/mabi.202200386
    Azadbakht A, Alizadeh S, Aliakbar Ahovan Z, Khosrowpour Z, Majidi M, Pakzad S, Shojaei S, Chauhan NPS, Jafari M, Gholipourmalekabadi M (2022). Chitosan-Placental ECM Composite Thermos-Responsive Hydrogel as a Biomimetic Wound Dressing with Angiogenic Property.
  • DOI: 10.1007/s00253-022-12231-3
    Hagag YA, Said HS, Kenawy HI, Hassan R (2022). A novel pentavalent vaccine candidate completely protects against Acinetobacter baumannii in a mouse model of peritonitis.
  • DOI: 10.3390/ijerph192316095
    Gao L, Ma X (2022). Transcriptome Analysis of Acinetobacter baumannii in Rapid Response to Subinhibitory Concentration of Minocycline.
  • DOI: 10.12688/f1000research.122221.2
    Rivani E, Endraswari PD, Widodo ADW (2022). Growth kinetics of multiple Acinetobacter baumannii resistotype after meropenem-based antibiotic combination exposure.
  • DOI: 10.21203/rs.3.rs-2359505/v1
    Hillyer T, Benin BM, Sun C, Aguirre N, Willard B, Sham YY, Shin WS (2023). A novel strategy to characterize the pattern of beta-lactam antibiotic-induced drug resistance in Acinetobacter baumannii.
  • DOI: 10.18502/ijm.v14i4.10237
    Rezania N, Rahmati P, Noorbakhsh F, Farhadyar N, Lotfali E (2022). Investigation the effects of silver nanoparticles and gold nanoparticles on expression of bap and csu genes in biofilm formation of Acinetobacter baumannii.
  • DOI: 10.1101/2023.02.02.526753
    Distel JS, Di Venanzio G, Mackel JJ, Rosen DA, Feldman MF (2023). Replicative Acinetobacter baumannii strains interfere with phagosomal maturation by modulating the vacuolar pH.
  • DOI: 10.1038/s41598-023-36475-9
    Hillyer T, Benin BM, Sun C, Aguirre N, Willard B, Sham YY, Shin WS (2023). A novel strategy to characterize the pattern of beta-lactam antibiotic-induced drug resistance in Acinetobacter baumannii.
  • DOI: 10.1371/journal.ppat.1011173
    Distel JS, Di Venanzio G, Mackel JJ, Rosen DA, Feldman MF (2023). Replicative Acinetobacter baumannii strains interfere with phagosomal maturation by modulating the vacuolar pH.
  • DOI: 10.1007/s10123-023-00389-3
    Konig P, Averhoff B, Muller V (2023). K(+) homeostasis is important for survival of Acinetobacter baumannii ATCC 19606 in the nosocomial environment.
  • DOI: 10.1016/j.intimp.2023.110650
    Mansouri M, Sadeghpoor M, Abdollahi M, Vafaei AJ, Jalali Nadoushan M, Rasooli I (2023). Synergistic immunoprotection by Oma87 and Bap against Acinetobacter baumannii sepsis model.
  • DOI: 10.1016/j.micpath.2023.106262
    Mirali M, Jahangiri A, Jalali Nadoushan M, Rasooli I (2023). A two-protein cocktail elicits a protective immune response against Acinetobacter baumannii in a murine infection model.
  • DOI: 10.1111/1462-2920.16471
    Alberti L, Konig P, Zeidler S, Poehlein A, Daniel R, Averhoff B, Muller V (2023). Identification and characterization of a novel pathway for aldopentose degradation in Acinetobacter baumannii.
  • DOI: 10.3389/fcimb.2023.1229473
    Zafer MM, Hussein AFA, Al-Agamy MH, Radwan HH, Hamed SM (2023). Retained colistin susceptibility in clinical Acinetobacter baumannii isolates with multiple mutations in pmrCAB and lpxACD operons.
  • DOI: 10.1371/journal.pone.0296453
    Soontarach R, Srimanote P, Arechanajan B, Nakkaew A, Voravuthikunchai SP, Chusri S (2024). Characterization of a novel bacteriophage endolysin (LysAB1245) with extended lytic activity against distinct capsular types associated with Acinetobacter baumannii resistance.
  • DOI: 10.3390/microorganisms12020331
    Huang YW, Shu HY, Lin GH (2024). Gene Expression of Ethanol and Acetate Metabolic Pathways in the Acinetobacter baumannii EmaSR Regulon.
  • DOI: 10.1007/s10103-024-04037-8
    Aghaebrahimi Z, Sabaghzadeh J, Soudi S, Tanhayi Ahary M, Nabavi SH, Ranjbaran M (2024). Simultaneous effect of medicinal plants as natural photosensitizers and low-level laser on photodynamic inactivation.
  • DOI: 10.3390/ijms25073862
    Toh YH, Lin GH (2024). Roles of DJ41_1407 and DJ41_1408 in Acinetobacter baumannii ATCC19606 Virulence and Antibiotic Response.
  • DOI: 10.1007/s10096-024-04832-9
    Liao J, Huang J, Xia P, Yang B, Dang Z, Luo S, Tang S, Li Y, Han Q, Xia Y (2024). Molecular epidemiology and resistance mechanisms of tigecycline-non-susceptible Acinetobacter baumannii isolated from a tertiary care hospital in Chongqing, China.
  • DOI: 10.1016/j.ijantimicag.2024.107189
    Lacroix M, Moreau J, Zampaloni C, Bissantz C, Shirvani H, Marchand S, Couet W, Chauzy A (2024). Impact of nutritional factors on in vitro PK/PD modelling of polymyxin B against various strains of Acinetobacter baumannii.
  • DOI: 10.1556/030.2024.02268
    El Mrimar N, Belouad EM, Benaissa E, Bssaibis F, Jazouli M, El Alaoui MA, Maleb A, Elouennass M (2024). Genetic alterations in the pmrAB two-component system and lipid A biosynthesis genes of polymyxin-resistant Acinetobacter baumannii isolates.
  • DOI: 10.1021/acs.jproteome.4c00148
    Tkalec KI, Hayes AJ, Lim KS, Lewis JM, Davies MR, Scott NE (2024). Glycan-Tailored Glycoproteomic Analysis Reveals Serine is the Sole Residue Subjected to O-Linked Glycosylation in Acinetobacter baumannii.
  • DOI: 10.1128/spectrum.00086-24
    Sun C, Zhou D, He J, Liu H, Fu Y, Zhou Z, Leptihn S, Yu Y, Hua X, Xu Q (2024). A panel of genotypically and phenotypically diverse clinical Acinetobacter baumannii strains for novel antibiotic development.
  • DOI: 10.1128/genomeA.00431-16
    Buttimer C, O'Sullivan L, Elbreki M, Neve H, McAuliffe O, Ross RP, Hill C, O'Mahony J, Coffey A (2016). Genome Sequence of Jumbo Phage vB_AbaM_ME3 of Acinetobacter baumanni.
  • DOI: 10.3389/fmicb.2015.01249
    Bahador A, Raoofian R, Pourakbari B, Taheri M, Hashemizadeh Z, Hashemi FB (2015). Genotypic and Antimicrobial Susceptibility of Carbapenem-resistant Acinetobacter baumannii: Analysis of is Aba Elements and bla OXA-23-like Genes Including a New Variant.
Outside links and data sources
Retrieved 5 months ago via StrainInfo API (CC BY 4.0)

Metadata

Cannonical URL
https://seqco.de/s:25679
Local history
  • Registered 11 months ago
  • Last modified 5 months ago
© 2022-2025 The SeqCode Initiative
  All information contributed to the SeqCode Registry is released under the terms of the Creative Commons Attribution (CC BY) 4.0 license